Innovative Spinal Muscular Atrophy Treatment

Spinal muscular atrophy (SMA) is a genetic condition that affects motor neurons, causing progressive muscle weakness. This condition is caused by a mutation in the SMN1 gene, responsible for producing the SMN protein, essential for the survival of motor neurons. At the BTT Medical Institute, we use a modern and personalized approach to offer an effective alternative in controlling the disease. Through BTT technology, developed by Dr. Marc Abreu, the method employs brain-guided hyperthermia to stimulate biological processes that protect motor neurons and can aid in muscle recovery.

This treatment stimulates the production of heat shock proteins (HSPs) — essential molecules that protect cells from stress, stabilize misfolded proteins, assist in proper protein folding (acting as molecular chaperones), reduce cell death, protect motor neurons, decrease protein toxicity, and modulate inflammation.
These proteins play a key role in reducing the impact of SMA, helping to stabilize the condition and promote a better quality of life. The method is individually tailored for each patient and can be used as a complementary treatment for spinal muscular atrophy, enhancing the effectiveness of traditional therapies and supporting better outcomes.